Xiran He

834 total citations
41 papers, 608 citations indexed

About

Xiran He is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Xiran He has authored 41 papers receiving a total of 608 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 12 papers in Pulmonary and Respiratory Medicine and 11 papers in Oncology. Recurrent topics in Xiran He's work include Lung Cancer Treatments and Mutations (9 papers), Cancer therapeutics and mechanisms (4 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Xiran He is often cited by papers focused on Lung Cancer Treatments and Mutations (9 papers), Cancer therapeutics and mechanisms (4 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Xiran He collaborates with scholars based in China, United States and Ethiopia. Xiran He's co-authors include Pingping Li, Shuyan Han, Shantong Jiang, Quan Wang, Jinhui Tian, Kehu Yang, Yanna Jiao, Lei Zhou, Sidong Xiong and Jie Wang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Energy & Environmental Science and Journal of Virology.

In The Last Decade

Xiran He

39 papers receiving 601 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiran He China 15 241 214 123 89 89 41 608
Yuanfeng Yang China 15 299 1.2× 162 0.8× 153 1.2× 90 1.0× 75 0.8× 49 645
Yuhong Sun China 13 238 1.0× 124 0.6× 80 0.7× 80 0.9× 80 0.9× 25 576
Yong‐Seok Song United States 15 285 1.2× 159 0.7× 115 0.9× 98 1.1× 98 1.1× 50 693
Reyaz ur Rasool India 17 370 1.5× 174 0.8× 81 0.7× 64 0.7× 97 1.1× 26 694
Lijing Jiao China 16 298 1.2× 185 0.9× 146 1.2× 50 0.6× 124 1.4× 50 615
Xinxing Li China 15 264 1.1× 141 0.7× 46 0.4× 53 0.6× 92 1.0× 31 561
Hongsheng Lin China 13 337 1.4× 147 0.7× 91 0.7× 65 0.7× 79 0.9× 26 697

Countries citing papers authored by Xiran He

Since Specialization
Citations

This map shows the geographic impact of Xiran He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiran He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiran He more than expected).

Fields of papers citing papers by Xiran He

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiran He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiran He. The network helps show where Xiran He may publish in the future.

Co-authorship network of co-authors of Xiran He

This figure shows the co-authorship network connecting the top 25 collaborators of Xiran He. A scholar is included among the top collaborators of Xiran He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiran He. Xiran He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
He, Xiran, Peng Pan, Jun Wang, et al.. (2025). Cr-enhanced selective dealloying and sequential electrochemical reconstruction to tailor NiFe-based integrated catalysts for industrial-level water oxidation. Energy & Environmental Science. 18(18). 8697–8707. 1 indexed citations
2.
Wei, Lan, Qian Li, Xiaolu Li, et al.. (2025). ICAT drives lactylation of tumor-associated macrophages via the c-Myc-ENO1 axis to promote cervical cancer progression. Free Radical Biology and Medicine. 241. 316–329.
3.
He, Xiran, Bin Chen, Shuai He, Xin Su, & Yuanpeng Wu. (2023). Reversible emulsification based on pH-responsive surfactant with dynamic imine bond. Journal of Molecular Liquids. 394. 123792–123792. 4 indexed citations
4.
Zhang, Pei, Yang Du, Hua Bai, et al.. (2022). Optimized dose selective HDAC inhibitor tucidinostat overcomes anti-PD-L1 antibody resistance in experimental solid tumors. BMC Medicine. 20(1). 435–435. 26 indexed citations
5.
Wei, Xia, Xiran He, Dongmei Zhang, & Xin Su. (2022). CO2-Responsive Wormlike Micelles Based on Pseudo-Tetrameric Surfactant. Molecules. 27(22). 7922–7922. 11 indexed citations
6.
Yu, Ruofei, Hua Bai, Jiefei Han, et al.. (2021). TP53 mutations in circulating tumor DNA in advanced epidermal growth factor receptor-mutant lung adenocarcinoma patients treated with gefitinib. Translational Oncology. 14(9). 101163–101163. 17 indexed citations
7.
Ouyang, Qing, Guohai Liang, Xiaoyu Tan, et al.. (2021). Evaluation of the ex vivo liver viability using a nuclear magnetic resonance relaxation time-based assay in a porcine machine perfusion model. Scientific Reports. 11(1). 4117–4117. 4 indexed citations
8.
Liu, Lixing, Xiran He, & Feng Li. (2019). Exercise on quality of life and cancer-related fatigue for lymphoma survivors: a systematic review and meta-analysis. Supportive Care in Cancer. 27(11). 4069–4082. 22 indexed citations
11.
Li, Xiaohong, Xiran He, Yanyan Zhou, et al.. (2017). Taraxacum mongolicum extract induced endoplasmic reticulum stress associated-apoptosis in triple-negative breast cancer cells. Journal of Ethnopharmacology. 206. 55–64. 45 indexed citations
12.
Han, Shuyan, et al.. (2016). Xiaoaiping injection combined with gefitinib inhibits resistant non-small cell lung cancer xenografts H460 and H1975. 30(1). 52. 1 indexed citations
13.
Zheng, Nan, Xiran He, Shantong Jiang, et al.. (2016). Simultaneous determination of gefitinib and its major metabolites in mouse plasma by HPLC–MS/MS and its application to a pharmacokinetics study. Journal of Chromatography B. 1011. 215–222. 34 indexed citations
14.
He, Xiran, Shuyan Han, & Pingping Li. (2016). Recent highlights of Chinese medicine for advanced lung cancer. Chinese Journal of Integrative Medicine. 23(5). 323–330. 12 indexed citations
15.
He, Xiran, Shuyan Han, & Pingping Li. (2016). Injectable Chinese herbal formula Kang'ai for nonsmall cell lung cancer: Trial sequential analysis of 2,259 participants from 31 randomized controlled trials. Journal of Cancer Research and Therapeutics. 12(2). 735–743. 8 indexed citations
16.
He, Xiran, Yonghong Chen, Huawen Li, et al.. (2015). Analysis of Sudan I in Food by QuEChERS Combined with Ultrasound-assisted Dispersive Liquid-liquid Microextraction with Solidification of Floating Organic Drop (UADLLME-SFO) Prior to HPLC-PAD. Food Science and Technology Research. 21(5). 659–664. 12 indexed citations
17.
He, Xiran, Shuyan Han, & Pingping Li. (2015). Recent highlights of experimental research for inhibiting tumor growth by using Chinese medicine. Chinese Journal of Integrative Medicine. 21(10). 727–732. 5 indexed citations
18.
Wang, Quan, Xiran He, Jinhui Tian, & Kehu Yang. (2013). Pancreatic Duct Stents at Pancreaticoduodenectomy: A Meta-Analysis. Digestive Surgery. 30(4-6). 415–424. 32 indexed citations
19.
He, Xiran, Quan Wang, & Pingping Li. (2013). Acupuncture and Moxibustion for Cancer-related Fatigue: a Systematic Review and Meta-analysis. Asian Pacific Journal of Cancer Prevention. 14(5). 3067–3074. 43 indexed citations
20.
Wang, Quan, et al.. (2013). Hand-Sewn Versus Stapled Esophagogastric Anastomosis in the Neck: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Indian Journal of Surgery. 77(2). 133–140. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026